Most sleep medicine guidelines recommend CPAP for moderate to severe obstructive sleep apnea, which generally means an apnea-hypopnea index (AHI) of 15 or higher. For mild sleep apnea (AHI between 5 and 14), CPAP is still recommended when you have significant daytime sleepiness or other bothersome symptoms. The picture is more nuanced than a single number, though, because the same AHI can mean very different things for different people depending on symptoms, cardiovascular risk, and how the sleep study itself was scored.
How Sleep Apnea Severity Is Classified
The standard severity scale used in sleep medicine divides obstructive sleep apnea into three tiers based on the AHI, which counts how many times per hour your breathing partially or fully stops during sleep. Mild sleep apnea is an AHI of 5 to 14, moderate is 15 to 30, and severe is above 30.1Sleep. Sleep Apnea Severity Classification — Revisited An AHI under 5 is considered normal in adults. These cutoffs have been in use for decades and are the foundation of almost every treatment decision, insurance policy, and research study in the field.
The numbers can sound abstract, but they translate to real disruption. An AHI of 30 means your breathing is interrupted at least once every two minutes throughout the night. Even an AHI of 15 means you’re being pulled out of restorative sleep roughly every four minutes. Your brain may partially wake each time to restart breathing, even if you never become fully conscious, and the cumulative effect is what drives the fatigue, cognitive fog, and health risks associated with untreated sleep apnea.
What the Clinical Guidelines Recommend
The American Academy of Sleep Medicine (AASM) published its most recent clinical practice guideline on positive airway pressure therapy with a strong recommendation: CPAP should be used, compared to no therapy, for adults with obstructive sleep apnea who have excessive daytime sleepiness.2PubMed Central. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline That “strong” designation is the highest confidence level the AASM uses, and it applies regardless of whether your AHI is 6 or 60, as long as you’re experiencing meaningful sleepiness.
In practice, this means if you have moderate or severe sleep apnea, CPAP is almost always the first-line treatment your doctor will suggest. The evidence for cardiovascular and mortality benefit is strongest in this range. For mild sleep apnea without noticeable sleepiness, the recommendation is less clear-cut, and this is where the conversation between you and your sleep specialist matters most.
Why Moderate and Severe Sleep Apnea Get Urgent Attention
The push toward CPAP at moderate-to-severe levels is driven largely by cardiovascular risk. Untreated moderate or severe sleep apnea raises the likelihood of coronary artery disease, heart failure, stroke, and abnormal heart rhythms, and it worsens outcomes if you already have any of these conditions.3PubMed. What Level of Sleep Apnea Requires a CPAP? The mechanism involves repeated drops in blood oxygen throughout the night, surges in stress hormones, and spikes in blood pressure that collectively strain the heart and blood vessels over months and years.
A study tracking patients with severe obstructive sleep apnea found that CPAP use of at least four hours per night was associated with lower mortality rates, particularly in men and in people over 50.4PubMed Central. Assessment of multiple health risks in a single obstructive sleep apnea population Four hours is often cited as a minimum threshold for meaningful benefit, though more is generally better. The data on severe sleep apnea and mortality is one reason sleep physicians tend to be insistent about CPAP for patients in this range, even when symptoms don’t feel dramatic.
The Case for Treating Mild to Moderate Sleep Apnea
One of the more striking findings in recent years is that cardiovascular risk isn’t limited to the severe end of the spectrum. A study following patients with mild to moderate sleep apnea over a decade found that treated patients had substantially fewer cardiovascular events than untreated ones. Estimated event-free survival at ten years was about 80% in the treated group compared to roughly 52% in the untreated group, and treatment was independently associated with a cardiovascular risk reduction of about 64% after adjusting for age, sex, and pre-existing conditions.5American Journal of Respiratory and Critical Care Medicine. Continuous Positive Airway Pressure Treatment of Mild to Moderate Obstructive Sleep Apnea Reduces Cardiovascular Risk The researchers concluded that treatment should be considered even in milder cases for cardiovascular prevention.
This kind of evidence complicates the old idea that mild sleep apnea is something to simply “keep an eye on.” If you have an AHI of 8 but also have high blood pressure, a family history of heart disease, or you’re a shift worker who can’t afford the cognitive effects of fragmented sleep, the risk-benefit calculation may tilt firmly toward treatment. The AHI threshold matters less than your overall health picture.
When Your Numbers Don’t Match How You Feel
One of the most frustrating aspects of sleep apnea diagnosis is that AHI scores often don’t correspond well to how miserable you actually feel. A study examining the relationship between sleep study numbers and patient-reported outcomes found essentially no consistent association between AHI and measures of sleepiness, quality of life, or reaction time.6PubMed. Polysomnography indexes are discordant with quality of life, symptoms, and reaction times in sleep apnea patients Some people with an AHI of 12 are barely functional during the day, while others with an AHI of 25 feel fine. The researchers noted that sleep study numbers may not capture some important aspects of disease burden, and that symptoms should be measured directly rather than assumed from the index.
This disconnect has real implications for treatment decisions. If your AHI is in the mild range but you’re dangerously sleepy while driving, that sleepiness alone is a strong indication for CPAP under the AASM guideline. Conversely, the debate around treating people who have elevated AHI scores but no daytime symptoms remains genuinely unresolved. An older controlled trial found that CPAP did not produce clear benefits in people who had abnormal sleep studies but no daytime sleepiness, raising the question of whether treating numbers alone makes sense for every patient.7PubMed. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial
The practical takeaway: your symptoms should weigh as heavily as your AHI in any treatment conversation. A skilled sleep specialist will ask about your energy level, driving safety, mood, cognitive function, and bed partner’s observations, not just hand you a number and a prescription.
CPAP Doesn’t Fix Everything for Everyone
Even when CPAP clearly helps, it doesn’t always eliminate sleepiness completely. A study of patients with moderate to severe sleep apnea found that among those who used CPAP more than seven hours per night, about 81% achieved a normal sleepiness score, meaning roughly one in five remained abnormally sleepy despite excellent compliance. Among those using CPAP only two to four hours per night, just over half reached normal sleepiness levels. Across the entire study group, only about 60% had normal sleepiness scores after treatment.8PubMed Central. The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSA
These numbers are worth knowing before you start treatment so you can set realistic expectations. If CPAP helps but doesn’t eliminate your sleepiness, it doesn’t necessarily mean the machine isn’t working. Other factors like insufficient sleep time, depression, or a separate sleep disorder can contribute to residual fatigue. The improvement tends to be dose-dependent: the more hours you use CPAP per night, the better the results, which is one reason sleep clinicians push for as many hours of use as possible rather than just clearing a minimum threshold.
The AHI Itself Isn’t as Standardized as You’d Think
A complication that most patients never hear about is that the rules for scoring the AHI have changed over time, and different scoring criteria can give you a substantially different number from the same night of sleep data. When the AASM updated its scoring manual, it introduced stricter criteria for what counts as a hypopnea (a partial breathing reduction). Under the stricter “recommended” definition, which required a 4% oxygen desaturation, median AHI values dropped to roughly 30% of what they would have been under the older criteria. Under an “alternative” definition requiring a 3% desaturation or an arousal, values were about 60% of the older numbers.9SLEEP. The New Aasm Criteria for Scoring Hypopneas: Impact on the Apnea Hypopnea Index
The practical fallout is significant: roughly 40% of patients who would have been classified as positive for sleep apnea under the older Chicago criteria would test negative under the stricter recommended definition, without any change in their actual breathing. If you’ve had two sleep studies at different labs and gotten wildly different AHI numbers, this is one reason why. It also means the classic severity cutoffs of 5, 15, and 30 don’t carry identical meaning across all scoring methods. When reviewing your results, it’s worth asking which hypopnea definition the lab used.
AHI Versus RDI
Some sleep reports list a respiratory disturbance index (RDI) rather than, or alongside, the AHI. The RDI includes everything the AHI counts plus respiratory effort-related arousals (RERAs), which are breathing events that disrupt sleep but don’t quite meet the criteria for a full apnea or hypopnea. In patients where the RDI is higher than the AHI, the disease tends to look more severe. One study found that patients whose RDI exceeded their AHI had a median RDI of about 54 events per hour, in the severe range, compared to about 27 for those whose RDI and AHI were equal.10PubMed Central. Factors associated with respiratory disturbance index higher than apnea-hypopnea index in patients with obstructive sleep apnea
If your sleep study shows a big gap between your AHI and your RDI, you may have a significant burden of subtler breathing events that fragment your sleep without appearing on the AHI. Some insurance policies and guidelines base their criteria on the AHI alone, which can leave patients with a low AHI but high RDI in a gray area. Discussing the RDI with your sleep physician can help clarify whether the AHI alone is telling the full story of your sleep disruption.
Alternatives to CPAP
CPAP is the gold standard, but it’s not the only option, especially for milder cases. Mandibular advancement devices, custom-fitted oral appliances that hold the lower jaw forward during sleep, have good evidence supporting their use in mild to moderate obstructive sleep apnea.11European Respiratory Journal. Non-CPAP therapies in obstructive sleep apnoea They’re generally less effective than CPAP at eliminating breathing events, but adherence tends to be better because many people find them more comfortable, and a treatment you actually use beats a theoretically superior one gathering dust on your nightstand.
Other alternatives include positional therapy for people whose apnea is much worse when sleeping on their back, weight loss in overweight patients, upper airway surgery, hypoglossal nerve stimulation (an implanted device that stimulates the tongue nerve to keep the airway open), and various pharmacological approaches.12PubMed Central. Non-CPAP Therapies for Obstructive Sleep Apnea in Adults Because sleep apnea presents differently from person to person, effective treatment often involves combining several of these approaches rather than relying on any single one.
Research into predicting which patients will respond well to oral appliances rather than CPAP has gotten more sophisticated. One approach uses routine sleep study data to estimate underlying traits of a patient’s sleep apnea, such as how collapsible the airway is, how easily the brain arouses, and how sensitive the breathing control system is, to predict who is likely to see at least a 50% reduction in AHI with an oral appliance.13Annals of the American Thoracic Society. Polysomnographic Endotyping to Select Patients with Obstructive Sleep Apnea for Oral Appliances This kind of personalized matching could eventually reduce the trial-and-error that many patients go through when choosing a treatment.
Sleep Position and REM Sleep Complicate the Picture
Your AHI is an average across the entire night, but sleep apnea severity can vary dramatically depending on your sleep position and sleep stage. Many people have positional sleep apnea, meaning their breathing is much worse on their back than on their side. In one study, the required CPAP pressure to eliminate apneas was significantly higher when patients slept supine (about 10 cm of water pressure) compared to sleeping on their side (about 7.6 cm), and this held true regardless of weight.14PubMed. The sleep supine position has a major effect on optimal nasal continuous positive airway pressure If your sleep study happened to catch you mostly on your back, your AHI may look worse than a typical night. The reverse is also true.
REM sleep, the dream stage, also tends to worsen apnea because of the natural muscle relaxation that occurs during it. Research has found that about 41% of patients who show positional sleep apnea during lighter sleep stages lose that positional benefit during REM sleep, meaning their breathing becomes problematic regardless of position.15Sleep. Relations Between Sleep Stage, Posture and Effective Nasal CPAP Levels in OSA If you had a short or disrupted sleep study with very little REM sleep, your AHI might underestimate the true severity.
Central Sleep Apnea Is a Different Problem
Everything discussed so far applies to obstructive sleep apnea, where the airway physically collapses during sleep. Central sleep apnea is a separate condition in which the brain temporarily stops sending the signal to breathe. The two can coexist, and distinguishing between them matters because treatment differs. Standard CPAP remains a front-line therapy for central sleep apnea, but other options include adaptive-servo ventilation (ASV), supplemental oxygen, phrenic nerve stimulation, and certain medications.16PubMed Central. Central Sleep Apnea: a Brief Review One critical exception: ASV is contraindicated in patients with central sleep apnea who also have heart failure with reduced pumping function, because it was linked to increased mortality in that population. If you’ve been told you have central apnea and you have heart failure, make sure your cardiologist and sleep specialist are communicating.
Pediatric Thresholds Are Much Lower
If you’re reading this for a child, the numbers are completely different. In children, an AHI above 1 is already considered abnormal, and the severity scale is shifted downward: mild is typically an AHI under 5, moderate is 5 to 10, and severe is above 10.17PubMed Central. Diagnosis and Treatment of Sleep Apnea in Children: A Future Perspective Is Needed A child with an AHI of 12 has severe sleep apnea by pediatric standards, even though the same number would be classified as mild in an adult. Treatment in children often starts with adenotonsillectomy rather than CPAP, though CPAP or other therapies may be needed if surgery doesn’t resolve the problem.
Home Testing Versus Lab Studies
Many sleep apnea diagnoses now happen through home sleep tests rather than overnight stays in a sleep lab. Home portable monitors have shown high sensitivity for detecting sleep apnea, picking up the vast majority of cases when compared against in-lab polysomnography.18PubMed. Diagnosis of obstructive sleep apnea syndrome and its outcomes with home portable monitoring However, home tests tend to have lower specificity, meaning they can overcall the severity in some cases. They also can’t measure total sleep time as accurately as a lab study, since they don’t monitor brain waves. Because the AHI is calculated as events per hour of sleep, and a home test might use total recording time rather than actual sleep time as the denominator, your home-test AHI could differ from what a lab study would show. If your results are borderline or don’t match your symptoms, an in-lab study can provide a more precise picture.
Insurance Rules and the 90-Day Clock
In the United States, insurance coverage for CPAP comes with strings attached. Medicare, which sets the template many private insurers follow, requires that you demonstrate adherence during a 90-day trial period. The specific criterion is use of CPAP for more than four hours on at least 70% of nights, or at least 21 days in any consecutive 30-day window during those first 90 days.19Sleep. Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea If you don’t meet this threshold, Medicare may stop covering the equipment and require a new sleep study before you can try again.20PubMed Central. Medicare long-term CPAP coverage policy: a cost-utility analysis
This compliance requirement can create real pressure during the adjustment period, which is exactly when most people struggle most with CPAP. Mask fit issues, pressure discomfort, nasal congestion, and simple unfamiliarity with sleeping while hooked to a machine all tend to be worst in the first few weeks. If you’re starting CPAP, it’s worth knowing about this timeline upfront so you can troubleshoot aggressively early on. Most CPAP providers and sleep labs offer support for mask fitting and pressure adjustments during this critical window, and taking advantage of that help can make the difference between keeping and losing your coverage.